Patents Assigned to LIFESCAN IP HOLDINGS, LLC
  • Patent number: 11872033
    Abstract: Systems, methods and graphical user interfaces for visualizing analyte measurements using animation are presented. For instance, a system for continuously monitoring analyte concentration in a physiological fluid includes a sensor, a transmitter, at least one processor and a display. The display is for outputting a graphical user interface. The display is controlled by the at least one processor to display, using the graphical user interface, historical analyte concentration levels and a trend indication animation. The trend indication animation comprises at least one visual element configured by the at least one processor to have a periodic motion between a first position and a second position on the display in one of a plurality of trend directions. The trend direction of the periodic motion between the first and second positions indicates whether the analyte concentration is increasing or decreasing and the rate of change of the analyte concentration level.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: January 16, 2024
    Assignee: Lifescan iP Holdings, LLC
    Inventors: Lisa Troncelliti, Mark Hofmeister, Allison Gonzales, David Shearer, Brian Levy, Bovornrat K. Cochard
  • Patent number: 11733198
    Abstract: A method for determining a concentration of an analyte in a fluidic sample is described. A sample is applied to a biosensor including an electrochemical cell having electrodes. A predetermined voltage waveform is applied during at least first and second time intervals. At least first and second current values are measured during the first and second time intervals, respectively. A turning point time is determined during the first time interval at which the measured first current values transition from a first to a second profile. The concentration of analyte in the sample is calculated based on determined turning point time and at least one measured current value. In another example, a physical characteristic of the sample is estimated based on measured current values. The concentration is calculated using a first or second model if the estimated physical characteristic of the sample is in a first or second range, respectively.
    Type: Grant
    Filed: June 14, 2021
    Date of Patent: August 22, 2023
    Assignee: LIFESCAN IP HOLDINGS, LLC
    Inventors: Zuifang Liu, David McColl, Robert Donald, Anna Salgado, Antony Smith
  • Patent number: 11604158
    Abstract: A method for determining contamination of a biosensor in which the biosensor is loaded into a test meter and a sample is then applied. First and second predetermined test voltages are applied between spaced electrodes of the biosensor for respective first and second predetermined time intervals. First and second current values are measured during the respective first and second predetermined time intervals. Reference values are determined based on the measured first and second current values. Based on one or more of the reference values, a determination of contamination is made. Reporting of the analyte concentration of the sample can be suppressed based on the determination.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: March 14, 2023
    Assignee: LifeScan IP Holdings, LLC
    Inventors: David McColl, Allan MacRae, Gavin MacFie, Stephen Mackintosh, David Morris, Joanne Watt, Antony Smith
  • Publication number: 20220400985
    Abstract: Systems and methods are provided for improved continuous glucose monitoring (“CGM”). The disclosed systems and methods provide for tracking analyte measurements, CGM-related event data, and sensor-related data. This data is combined and presented in connection with a graphical user interface that allows for improved functionality. Aspects of the disclosure allow for analyte measurements to be displayed in a graphical user interface that includes historical graphs of analyte measurements and incorporate event data as a plurality of event indications. The time frame of the historical graph can be altered by the user and the events can be presented a group within an event indication based on the time frame of the historical graph. The graphical user interface may also be configured to display graph trend data for each individual event as well as a sensor-life indication representing the period of time remaining before expiration of an analyte sensor.
    Type: Application
    Filed: June 18, 2021
    Publication date: December 22, 2022
    Applicant: LifeScan IP Holdings, LLC
    Inventors: Allison Gonzales, Lisa Troncelliti, Mark Hofmeister, Bovornrat Cochard
  • Patent number: 11497851
    Abstract: A system and a method for management of diabetes are provided. The system includes an infusion pump, glucose sensor, and controller that is programmed to control insulin delivery based upon at least one stored variable. The controller calculates a maximum insulin delivery rate based on the default basal insulin delivery rate, temporary basal insulin delivery rate, extended bolus rate, or a combination thereof.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: November 15, 2022
    Assignee: Lifescan IP Holdings, LLC
    Inventors: Daniel Finan, Pavel Vereshchetin
  • Patent number: 11162916
    Abstract: Various embodiments for methods and systems that allow for a more accurate analyte concentration with a biosensor by determining at least one physical characteristic of the sample containing the analyte and deriving one of a batch slope, sampling time, or combinations thereof to attain accurate glucose concentration.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: November 2, 2021
    Assignee: Lifescan IP Holdings, LLC
    Inventors: Michael Malecha, Antony Smith, David McColl
  • Patent number: 11147920
    Abstract: Systems and methods for diabetes management with automatic basal and manual bolus insulin control are presented. An exemplary system includes a delivery device, a glucose sensor, and a controller. The delivery device delivers insulin and the glucose sensor measures glucose levels of the subject. A basal insulin dose is calculated using a model predictive control algorithm and physiological data of the subject including desired glucose levels, amounts of the delivered insulin and the measured glucose levels. A manual bolus insulin dose is initiated by the subject. The manual bolus insulin dose is modified based on one or both of the model predictive control algorithm and the physiological data of the subject. A total insulin dose is determined based on the modified manual bolus insulin dose and the calculated basal insulin dose, and delivered to the subject.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: October 19, 2021
    Assignee: LifeScan IP Holdings, LLC
    Inventors: Daniel Finan, Thomas McCann, Jr.
  • Patent number: 11035819
    Abstract: A method for determining a concentration of an analyte in a fluidic sample is described. A sample is applied to a biosensor including an electrochemical cell having electrodes. A predetermined voltage waveform is applied during at least first and second time intervals. At least first and second current values are measured during the first and second time intervals, respectively. A turning point time is determined during the first time interval at which the measured first current values transition from a first to a second profile. The concentration of analyte in the sample is calculated based on determined turning point time and at least one measured current value. In another example, a physical characteristic of the sample is estimated based on measured current values. The concentration is calculated using a first or second model if the estimated physical characteristic of the sample is in a first or second range, respectively.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: June 15, 2021
    Assignee: LifeScan IP Holdings, LLC
    Inventors: Zuifang Liu, David McColl, Robert Donald, Anna Salgado, Antony Smith
  • Patent number: 10782352
    Abstract: A test meter and related method for monitoring the condition of a backlight battery of the meter in which the meter includes a housing, controller, display with backlight and a battery monitoring circuit. An off-time of the meter is measured and compared to a predetermined recovery time of the backlight battery. If the off-time of the meter is greater than the predetermined recovery time of the backlight battery, a voltage of the backlight battery is measured at a predetermined time after energizing the backlight and compared to a first predetermined voltage in excess of a threshold voltage of the backlight battery. If the measured voltage is less than the first predetermined voltage, the measured voltage is compared to a second predetermined voltage between the first predetermined voltage and the threshold voltage. A battery depletion warning is displayed if the measured voltage is less than the second predetermined voltage.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: September 22, 2020
    Assignee: LifeScan IP Holdings, LLC
    Inventors: David Elder, Brian Guthrie, Malcolm Hamer
  • Patent number: 10583249
    Abstract: A visualization and analysis tool is provided for an insulin delivery system, such as an artificial pancreas, in which insulin is delivered based upon a system algorithm using a pump that is patient controllable in order to adjust insulin delivery relative to a baseline delivery rate; e.g., pre-set basal rate and a sensor for measuring glucose levels. The tool is configured with a controller of the system to detect and log events that are based on differences between actual insulin delivered by the system and the baseline delivery rate. These detected events are metrics that provide information relating to the therapeutic value of the system which, without such metrics, may be overlooked or unnoticed, thereby fostering trust and confidence in the delivery system. In addition, information is provided which may enable further improved glucose control.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: March 10, 2020
    Assignee: LifeScan IP Holdings, LLC
    Inventors: Daniel Finan, Pavel Vereshchetin
  • Patent number: 10545132
    Abstract: A physiological measurement system includes a biosensor providing a signal for a fluid sample. A processor determines a physiological parameter in the form of an analyte concentration using the signal from the biosensor. A network interface conveys data between the processor and a social network. The processor can transmit a query for analyte-data-request records to the social network, receive an indication of an analyte-data-request record from the social network, and transmit the determined analyte data or physiologic data to the social network in response to the indication. The processor can alternatively retrieve user credentials from a storage device, transmit the credentials and the analyte data to the social network, retrieve from the social network different-user response data corresponding to the transmission, and present an indication of the response data. Methods for processing analyte or physiologic data are also described.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: January 28, 2020
    Assignee: LifeScan IP Holdings, LLC
    Inventors: Brian Guthrie, David Elder, Graeme Pringle, Damian Edward Haydon Baskeyfield
  • Patent number: 10520460
    Abstract: A method for determining a diffusion feature of a fluidic sample using redox reactions in an electrochemical cell that has at least two electrodes, wherein the first electrode has at least one redox mediator at its surface or in close vicinity of its surface, and the second electrode has an electrode surface free of the redox mediator(s) in the beginning of a test, the method comprising: applying an electric potential to a fluidic sample in the electrochemical cell to initiate redox reactions at the two electrode surfaces; measuring current associated with the applied potential as a function of time, and using a measurement point on a transient part of the measured current at or after a turning point and its associated time to determine the diffusion feature.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: December 31, 2019
    Assignee: LifeScan IP Holdings, LLC
    Inventors: Zuifang Liu, Magdalena Gutowska
  • Patent number: 10429337
    Abstract: Described and illustrated herein are systems and exemplary methods of operating an analyte measurement system having a meter and a test strip. In one embodiment, the method may be achieved by applying a first test voltage between a reference electrode and a second working electrode and applying a second test voltage between the reference electrode and a first working electrode; measuring a first test current, a second test current, a third test current and a fourth test current at the second working electrode after a blood sample containing an analyte is applied to the test strip; measuring a fifth test current at the first working electrode; estimating a hematocrit-corrected analyte concentration from the first, second, third, fourth and fifth test currents; and annunciating the hematocrit-corrected analyte concentration.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: October 1, 2019
    Assignee: LifeScan IP Holdings, LLC
    Inventors: Michael Malecha, Adam Craggs
  • Patent number: 10371660
    Abstract: Various embodiments for systems and methods that allow for a more accurate analyte concentration with a biosensor by obtaining two calibration codes, one for batch calibration due to manufacturing variations and the other for time calibration due to measured physical characteristics of the fluid sample.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: August 6, 2019
    Assignee: LifeScan IP Holdings, LLC
    Inventor: Michael Malecha
  • Patent number: 10371663
    Abstract: Methods for determining a concentration of an analyte in a sample, and the devices and systems used in conjunction with the same, are provided herein. In one exemplary embodiment of a method for determining a concentration of an analyte in a sample, a sample including an analyte is provided in a sample analyzing device having a working and a counter electrode. An electric potential is applied between the electrodes and a first analyte concentration is determined. A second analyte concentration value is calculated from the first analyte concentration value and corrected for temperature effects, fill time and capacitance to provide for a final analyte concentration value.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: August 6, 2019
    Assignee: LIFESCAN IP HOLDINGS, LLC
    Inventors: Ronald C. Chatelier, Alastair M. Hodges
  • Patent number: 10350348
    Abstract: A manually operated medicament infusion device is provided. The device is capable of delivering an accurately controlled volume of medicament with reliability. Additionally, the device includes a battery-operated indication device for tracking the number of doses of medication delivered. Optionally, the device includes a ratchet and pawl to prevent inadvertent dispensing of medicament.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: July 16, 2019
    Assignee: LifeScan IP Holdings, LLC
    Inventor: Stephen Heiman
  • Patent number: 10210538
    Abstract: An analyte measurement system includes a processor connected to a biosensor providing analyte data corresponding to an analyte level of a fluid sample. A user interface provides a menu of functions to a user and successively receives a plurality of menu choices, which the processor records. A storage device holds data defining a first action criterion. The processor compares the menu choices to the first action criterion. When the stored menu choices satisfy the first action criterion, the processor can automatically add a first additional function to the menu of functions, or can automatically presents a reward token via the user interface. The system can also include a housing holding the user interface, the storage device, and the processor. Methods are also disclosed.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: February 19, 2019
    Assignee: LifeScan IP Holdings, LLC
    Inventors: Brian Guthrie, Malcolm D. Hamer, Alexander Strachan, Kimberley A. Gibson, Jonathan Nelson
  • Patent number: 10188796
    Abstract: Described and illustrated is a system for management of diabetes that includes an infusion pump, glucose sensor and controller with a method programmed into the controller. The infusion pump is configured to deliver insulin to a subject. The system provides the user with the ability to understand the effects of bolus insulin dosing upon their glucose levels. Specifically, the system provides a message that must include: (a) the trend of the user's glucose; (b) the recommended bolus; and (c) the actual bolus.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: January 29, 2019
    Assignee: LifeScan IP Holdings, LLC
    Inventors: Sweta Chovanda, Carlos O. Morales
  • Patent number: 10151724
    Abstract: Methods for distinguishing between an aqueous non-blood sample (e.g., a control solution) and a blood sample are provided herein. In one aspect, the method includes using a test strip in which multiple current transients are measured by a meter electrically connected to an electrochemical test strip. The current transients are used to determine if a sample is a blood sample or an aqueous non-blood sample based on characteristics of the sample (e.g., amount of interferent present, reaction kinetics, and/or capacitance). The method can also include calculating a discrimination criteria based upon these characteristics. Various aspects of a system for distinguishing between a blood sample and an aqueous non-blood sample are also provided herein.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: December 11, 2018
    Assignee: LIFESCAN IP HOLDINGS, LLC
    Inventors: Ronald C. Chatelier, Alastair M. Hodges
  • Patent number: D841660
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: February 26, 2019
    Assignee: LifeScan IP Holdings, LLC
    Inventor: Daniel Mercado